Microbes in the gut: A digestable account of host-symbiont interactions

Indian Journal of Medical Research

Volumn 128, Issue 5, 2008, Pages 587-594

  Pai, Rekha ^a   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Barrier; GALT; Microbiota; Nutrient absorption; Symbiotic

Indexed keywords

SHORT CHAIN FATTY ACID;

ANGIOGENESIS; BACTERIAL COLONIZATION; BACTEROIDES; CELL LINEAGE; ENTERITIS; HOMEOSTASIS; HOST PARASITE INTERACTION; HUMAN; INTESTINE CELL; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; INTESTINE MOTILITY; MICROBIAL COMMUNITY; MORPHOGENESIS; NONHUMAN; NUTRIENT UPTAKE; PERMEABILITY BARRIER; POSTNATAL DEVELOPMENT; PSEUDOMEMBRANOUS COLITIS; REVIEW; SYMBIOSIS;

ANIMALS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL LINEAGE; GASTROINTESTINAL MOTILITY; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; LYMPHOID TISSUE; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; SYMBIOSIS; TOLL-LIKE RECEPTORS;

EID: 61849118447     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Xu J, Gordon JI. Inaugural Article: Honor thy symbionts. Proc Natl Acad Sci USA 2003; 100: 10452-9.
2. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107-33.
3. Kraehenbuhl JP, Corbett M. Immunology. Keeping the gut microflora at bay. Science 2004; 303: 1624-5.
4. Backhed F, Ley RE, Sonnenburg JA, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-20.
5. Lievin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006; 19: 315-37.
6. Raibaud P. Bacterial interactions in the gut. In: Fuller R, editor. Probiotics- The scientific basis. London: Chapman & Hall; 1992. p. 9-28.
7. Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 2005; 71: 4679-89.
8. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from Gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157-70.
9. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002; 22: 283-307.
10. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
11. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430-5.
12. Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 2002; 56: 117-37.
13. Coconnier-Polter MH, Lievin-Le Moal V, Servin AL. A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage. Appl Environ Microbiol 2005; 71: 6115-20.
14. Cheng Q, Hwa V, Salyers AA. A locus that contributes to colonization of the intestinal tract by Bacteroides thetaiotaomicron contains a single regulatory gene (chuR) that links two polysaccharide utilization pathways. J Bacteriol 1992; 174: 7185-93.
15. Moreau MC, Ducluzeau R, Raibaud P. Hydrolysis of urea in the gastrointestinal tract of "monoxenic" rats: effect of immunization with strains of ureolytic bacteria. Infect Immun 1976; 13: 9-15.
16. Carlstedt-Duke B, Midtvedt T, Nord CE, Gustafsson BE. Isolation and characterization of a mucin-degrading strain of Peptostreptococcus from rat intestinal tract. Acta Pathol Microbiol Immunol Scand (B) 1986; 94: 293-300.
17. MacDonald TT, Monteleone G. Immunity, inflammation and allergy in the gut. Science 2005; 307: 1920-5.
18. Tannock GW. What immunologists should know about bacterial communities of the human bowel. Semin Immunol 2007; 19: 94-105.
19. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: 1558-72.
20. Savage DC. Microbial biota of the human intestine: a tribute to some pioneering scientists. Curr Issues Intest Microbiol 2001; 2: 1-15.
21. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-8.
22. Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol 2004; 70: 3189-94.
23. Brandi G, Biavati B, Calabrese C, Granata M, Nannetti A, Mattarelli P, et al. Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol 2006; 101: 1756-61.
24. Brandi G, Pisi A, Biasco G, Miglioli M, Biavati B, Barbara L. Bacteria in biopsies of human hypochlorhydric stomach: a scanning electron microscopy study. Ultrastruct Pathol 1996; 20: 203-9.
25. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006; 103: 732-7.
26. Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol 2005; 54: 1093-101.
27. Su WJ, Bourlioux P, Bournaud M, Besnier MO, Fourniat J. Transfer of the cecal flora of the hamster to the germfree C3H mouse: use of this model to study the flora of the anti-Clostridium difficile barrier. Can J Microbiol 1986; 32: 132-6.
28. Boureau H, Decre D, Carlier JP, Guichet C, Bourlioux P. Identification of a Clostridium cocleatum strain involved in an anti- Clostridium difficile barrier effect and determination of its mucin-degrading enzymes. Res Microbiol 1993; 144: 405-10.
29. Gomez A, Ladire M, Marcille F, Fons M. Trypsin mediates growth phase-dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a antibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota. J Bacteriol 2002; 184: 18-28.
30. Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, et al. Ruminococcin A, a new antibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol 2001; 67: 4111-8.
31. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004; 28: 405-40.
32. Macnab RM. How bacteria assemble flagella. Annu Rev Microbiol 2003; 57: 77-100.
33. Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 2005; 73: 5183-8.
34. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4: 269-73.
35. Wostmann BS, Larkin C, Moriarty A, Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 1983; 33: 46-50.
36. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-41.
37. Salyers AA, O'Brien M. Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacteriol 1980; 143: 772-80.
38. Cheng Q, Yu MC, Reeves AR, Salyers AA. Identification and characterization of a Bacteroides gene, csuF, which encodes an outer membrane protein that is essential for growth on chondroitin sulfate. J Bacteriol 1995; 177: 3721-7.
39. Alam M, Midtvedt T, Uribe A. Differential cell kinetics in the ileum and colon of germfree rats. Scand J Gastroenterol 1994; 29: 445-51.
40. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100: 2560-8.
41. Iwai H, Ishihara Y, Yamanaka J, Ito T. Effects of bacterial flora on cecal size and transit rate of intestinal contents in mice. Jpn J Exp Med 1973; 43: 297-305.
42. Cherbut C, Aubé AC, Blottière HM, Pacaud P, Scarpignato C, Galmiche JP. In vitro contractile effects of short chain fatty acids in the rat terminal ileum. Gut 1996; 38: 53-8.
43. Rondeau MP, Meltzer K, Michel KE, McManus CM, Washabau RJ. Short chain fatty acids stimulate feline colonic smooth muscle contraction. J Feline Med Surg 2003; 5: 167-73.
44. Uribe A, Alam M, Johansson O, Midtvedt T, Theodorsson E. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 1994; 107: 1259-69.
45. Bry L. Falk PG, Gordon JL. Genetic engineering of carbohydrate biosynthetic pathways in transgenic mice demonstrates cell cycle-associated regulation of glyconconjugate production in small intestinal epithelial cells. Proc Natl Acad Sci USA 1996; 93: 1161-6.
46. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99: 15451-5.
47. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004; 4: 953-64.
48. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289: 1560-3.
49. Matsumoto S, Setoyama H, Imaoka A, Okada Y, Amasaki H, Suzuki K, et al. Gamma delta TCR-bearing intraepithelial lymphocytes regulate class II major histocompatibility complex molecule expression on the mouse small intestinal epithelium. Epithelial Cell Biol 1995; 4: 163-70.
50. Wilcox HM. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 2003; 17: 475-93.
51. Neu H. The crisis in antibiotic resistance. Science 1992; 257: 1064-73.
52. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-55.
53. Oelschlaeger TA, Dobrindt U, Hacker J. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int J Antimicrob Agents 2002; 19: 517-21.
54. Shanahan F. Probiotics in inflamatory bowel disease. Gut 2001; 48: 609.
55. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-23.